Your session is about to expire
← Back to Search
Brain Stimulation for Alzheimer's Disease (ISTIM-AD Trial)
ISTIM-AD Trial Summary
This trial will test if a brain stimulation intervention can help improve cognitive function, mobility, and other measures in older adults with mild Alzheimer's disease.
ISTIM-AD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowISTIM-AD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ISTIM-AD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 65 or older and live in a supportive housing facility.I have a history of neurological conditions other than mild Alzheimer's Disease.I need someone's help to walk, but I can use a cane or walker.I don't have seizures, use certain drugs, have metal in my body, specific implants, or scalp conditions.I have mild Alzheimer's with some memory loss and daily activity challenges.I have severe depression based on a specific depression scale score.I am currently taking medication for mental health, seizures, or other brain-related conditions.I have been diagnosed with schizophrenia, bipolar disorder, or another psychiatric condition.I have severe arthritis in my legs or diagnosed nerve damage.I am willing to follow the study's requirements.
- Group 1: Personalized tDCS
- Group 2: Active-Sham
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacant positions in this clinical trial?
"Affirmative. Information hosted on clinicaltrials.gov reflects that this medical trial is actively seeking patients for enrolment. This initiative was first posted in January 2021 and most recently updated in March 2022; it requires 24 participants from a single site."
What objectives does this experiment seek to accomplish?
"The primary goal of this clinical trial, to be measured over two weeks, is to evaluate dual task standing postural sway area. Secondary objectives include assessing mobility with the Timed Up-and-Go test and quantifying habitual physical activity and postural control while performing a cognitive task through Five-day accelerometry-based physical activity and Dual Task Standing Postural Sway Speed tests respectively."
What is the aggregate patient count for this clinical trial?
"Affirmative. The clinical trial registry states that this research initiative is actively searching for subjects. It was first listed on January 31st 2020 and the latest update occurred on March 14th 2022. 24 individuals are being sought from one medical facility."
Share this study with friends
Copy Link
Messenger